Amyloid pathology in cognitively normal older adults has been associated with low memory performance and cognitive complaints, but findings are conflicting. Using a monozygotic twin design we further explored this relation. We investigated 199 cognitively normal older adults (96 twin-pairs) and assessed cognitive performance, cognitive complaints and amyloid pathology on positron emission tomography (PET) and in cerebrospinal fluid (CSF).
Introduction
Alzheimer's disease (AD) is characterized by aggregation of amyloid-beta in the brain, which may start up to 20 years before dementia onset (Jansen, et al., 2015 ,Villemagne, et al., 2013 .
Identification of cognitively normal individuals at risk for amyloid aggregation is important as this will help to select participants for treatment studies in a stage when neurodegeneration is still limited. Previous studies showed that amyloid pathology in cognitively normal individuals may be associated with low-normal memory performance and cognitive complaints but findings have been conflicting (Chetelat, et al., 2010 ,Jansen, et al., 2017 ,Perrotin, et al., 2012 . This may be due to variability in memory tests and amyloid measures used. In particular in cognitively normal older adults, cerebrospinal fluid (CSF) amyloid markers may be more sensitive for amyloid pathology than positron emission tomography (PET) amyloid markers (Palmqvist, et al., 2016) . Furthermore, it is not clear whether the relation between amyloid pathology and cognitive performance has a common underlying biology.
Aim of this study is to investigate the relation of amyloid pathology, assessed by dynamic [
18 F]flutemetamol amyloid PET scan and amyloid-β 1-42/1-40 ratio (Aβ 42/40 ) in CSF, with memory performance, assessed with four memory tests, and degree of cognitive complaints in cognitively normal older adults using a monozygotic twin-pair approach. Monozygotic twins provide an unparalleled opportunity to explore the etiology of comorbidity among traits.
Monozygotic twins share 100% of their genes. If two traits are influenced by the same genes, it follows that an across-participant association between traits will result in cross-trait association between twins from a pair. If amyloid pathology and memory dysfunction have a shared biology, we then expect that amyloid pathology in one twin will predict memory performance in the co-twin (De Moor, et al., 2008 ,Vitaro F, 2009 ). In case within twin-pair differences in amyloid markers correlate with within twin-pair differences in memory M A N U S C R I P T
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Methods

Participants
We selected 199 cognitively normal monozygotic twins (96 complete pairs, and 7 twins of which the co-twin was not able to participate or did not have a measure for amyloid available) from the Netherlands Twin Register (Willemsen, et al., 2013) , who we enrolled in the European Information Framework for AD (EMIF-AD)-PreclinAD study (Konijnenberg, et al., 2018) . Inclusion criteria were age ≥60 years and older, a delayed recall score >-1.5 SD of demographically adjusted normative data on the Consortium to Establish a Registry for Alzheimer's Disease 10 word list (Morris, et al., 1989) , a Telephone Interview for Cognitive
Status modified score ≥23 (de Jager, et al., 2003) , a 15-item Geriatric Depression Scale score of <11 (Yesavage, et al., 1982) , and a Clinical Dementia Rating score of 0 (Morris, 1993) .
Exclusion criteria were any significant neurologic, systemic, or psychiatric disorder that could cause cognitive impairment. Twin zygosity was confirmed by buccal cell DNA analysis. 
Assessment of memory performance and cognitive complaints
Cognitive complaints were assessed using the Cognitive Complaints Index (CCI), consisting of 20 questions on memory performance compared to five years ago (Rattanabannakit, et al., M A N U S C R I P T
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Amyloid and memory in cognitively normal older adults - Konijnenberg et al. 2018 6 2016). We used this self-reported score since in cognitively normal adults self-reported complaints are supposed to best reflect actual disease (Buckley, et al., 2015) . We selected four memory tests that differed in type of material presented (verbal versus visual) and learning paradigm (unrelated items versus association between items), which were previously associated with amyloid pathology: the Rey complex figure three minute recall (visuospatial memory) (Meyers, et al., 1996 ,Snitz, et al., 2013 , total score from the FNAME-names delayed recall (face-name associative memory) (Papp, et al., 2014 ,Rentz, et al., 2011 , CANTAB Paired Associate Learning total errors adjusted (visual associative memory) (Reijs, et al., 2017 ,Robbins, et al., 1994 , and the Rey auditory verbal learning task delayed recall (verbal memory) (Rey, 1964 ,Tolboom, et al., 2009a and 2pm, after at least two hours of fasting. CSF was collected in Sarstedt polypropylene syringes using a Spinocan 25 Gauge needle in intervertebral spaces between L3 and S1.
Samples were centrifuged at 1300-2000g at 4°C for 10 minutes and supernatants were stored in aliquots of 0.5 mL at -80°C until analysis. A maximum of 2 hours was allowed between lumbar puncture and freezing (del Campo, et al., 2012) . Levels of amyloid-β 1-42 and 1-40 M A N U S C R I P T
Amyloid and memory in cognitively normal older adults - Konijnenberg et al. 2018 7 were analyzed using kits from the same batch according to manufacturer instructions (ADx Neurosciences/Euroimmun) . (Nelissen, et al., 2009) . After an interval of 60 minutes, in which the patient was taken from the scanner bed, a second scan of 20 minutes was acquired, starting 90 minutes after injection. Prior to each part of the PET scan a dedicated MR sequence was obtained for attenuation correction. PET scans were reconstructed using the LOR-RAMLA dedicated Philips reconstruction algorithm for the brain into 18 frames of increasing length (6x5, 3x10, 4x60, 2x150, 2x300, 1x600 s) and into 4 frames of 300s each. Data from two scans were combined into a single image data set after co-registration using Vinci Software 2.56 and in-house built software for decay correction of the second part. Regions of interest were automatically delineated based on the T1-MRI images using the Hammers atlas as implemented in PVElab (Hammers, et al., 2003 ,Svarer, et al., 2005 . Parametric non-displaceable binding potential (BP ND ) images were generated from the entire image set using the receptor parametric mapping and cerebellar grey matter as reference tissue (Gunn, et al., 1997,Wu and Carson, 2002) . Global cortical BP ND was calculated as the average BP ND of 22 regions located within frontal, parietal, temporal, posterior cingulate and medial temporal lobes (Tolboom, et al., 2009b) . Visual read on the dynamic BP ND [ 18 F]flutemetamol images as negative or positive was applied by the consensus of three readers, blinded to the clinical and demographic data.
Positron emission tomography scanning
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APOE genotype
Apolipoprotein E (APOE) genotype was assessed based on two SNPs (rs429358, rs7412), genotyped on the Affymetrix Axiom array (Ehli, et al., 2017) ; for two participants APOE data was missing.
Statistical analysis
Statistical analyses were performed in SPSS version 23 for Windows and RStudio version 3.3.1(http://www.r-project.org/). Amyloid PET BP ND values were skewed, therefore logtransformation was used to normalize the data. Z-scores were used for all markers, obtained as standardized variables with a mean of 0 and a standard deviation of 1 (using the sample mean and standard deviation). Across-participant associations were assessed using
Generalized Estimating Equations (GEE) with PET (dichotomous and continuous) or the CSF
Aβ 42/40 ratio (continuous) as predictors and memory performance or CCI as outcome variables adjusted for clustering of twins within pairs (model 1) and for clustering of twins within pairs, age, gender, and education (model 2) (Minica, et al., 2014) . When observing a significant effect for a covariate we subsequently tested for a interaction.
When a significant (Bonferroni-corrected p = 0.05/(5tasks*2amyloid measures) =0.005) across-participant association was found, we further examined whether amyloid in one twin could predict memory or CCI in its co-twin, by estimating the cross-twin cross-trait correlations in OpenMx in R (figure 1b) (Boker, et al., 2011) . We used the monozygotic within twin-pair difference model (De Moor, et al., 2008) to test whether our data supports a direct relation between amyloid, memory and CCI. In monozygotic twin-pairs, the variances and covariances of difference scores are a function of unique environmental factors that influence the two traits and the correlation between these environmental factors. A significant relation between difference scores implies a correlation between unique environmental M A N U S C R I P T
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Amyloid and memory in cognitively normal older adults - Konijnenberg et al. 2018 9 factors, that also is compatible with a direct influence of one trait on the other trait (Boomsma, et al., 2005) . For this analysis we regressed within twin-pair differences in memory performance or CCI on within twin-pair differences in amyloid load (figure 1c). We used a monozygotic twin discordance model based on amyloid-aggregation as measured by visual read of the PET scan and tested whether twin-pairs concordant for having an amyloidnegative PET scan (referred to as concordant negative/control group) differ from, discordant twin-pairs where one twin has an amyloid-negative PET scan (discordant negative group) and the co-twin has an amyloid-positive PET scan (discordant positive group) and twin-pairs concordant for having an amyloid-positive PET scan (concordant positive group). This model can function as a disease stage model, where twins discordant for amyloid pathology might be in an earlier amyloid stage compared to twins with both amyloid pathology. We tested whether group status (concordant negative, discordant negative, discordant positive and concordant positive) was associated with memory performance or CCI , adjusted for clustering of twins within pairs, age, gender and education using GEE.
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Sample characteristics
We included 199 participants of which 196 had a PET visual read, 188 had dynamic PET BP ND data, and 126 had CSF available. Participants were on average 70.5 years, 57% was female, and 33% carried at least one APOE-ε4 allele. The subgroup of 118 participants with both dynamic PET and CSF data was younger compared to participants with PET only ( M A N U S C R I P T
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Cross-twin pair correlation between amyloid aggregation and memory performance
Since we observed a significant relation between amyloid aggregation with Rey visuospatial memory performance, we further tested the influence of shared genetic/environmental factors.
We found that CSF Aβ 42/40 ratio in one twin could predict Rey visuospatial memory score in the co-twin (r=0.20, p=0.04) but this association was not statistically significant after correction for age (r=0.08, p=0.41). This suggests that the relation between amyloid aggregation and visual memory performance is partly driven by factors that are shared within identical twin-pairs (genes/environment)
Within twin-pair difference association between amyloid aggregation and memory performance
We also tested the influence of non-shared environmental factors on the relation between amyloid aggregation and Rey visuospatial memory performance by twin-pair difference analysis but did not observe a significant association between twin-pair difference in amyloid aggregation and twin-pair difference Rey visuospatial memory performance, suggesting nonshared environmental factors do not contribute to the observed association (figure 2b).
Monozygotic twin discordance analysis -disease stage model
Finally, we tested possible effects of disease staging using the twin discordance model. This model can be used as a staging model for amyloid pathology, with concordant negative twinpairs being the control group, discordant twins with a negative amyloid PET scan in a preamyloid stage, followed by discordant co-twins with a positive amyloid PET scan, and twinpairs concordant for having a positive amyloid PET scan reflecting a more advanced stage of the disease. Fourteen twin-pairs were discordant (one twin had a negative amyloid PET scan and its co-twin had an positive amyloid PET scan), in 74 twin-pairs both twins had negative M A N U S C R I P T
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M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT
Amyloid and memory in cognitively normal older adults - Konijnenberg et al. 2018 13
Discussion
We found amyloid pathology to be associated with lower visual memory performance in cognitively normal older adults. Participants with higher levels of amyloid aggregation, measured with both PET and in CSF, showed worse visuospatial memory performance (Rey complex figure) . We found no association between verbal memory performance and amyloid pathology, cognitive complaints and amyloid pathology nor between cognitive complaints and memory performance.
Amyloid aggregation and memory performance
Visuospatial memory
The Rey complex figure (visuospatial memory) task was found to be associated with amyloid pathology both on PET (visual read) and in CSF (Aβ 42/40 ratio). These results are in line with a previous study showing decline in Rey visuospatial memory performance to be associated with amyloid pathology at follow-up (Snitz, et al., 2013) . Our monozygotic twin-pair analysis showed that CSF Aβ 42/40 ratio in one twin could predict Rey visuospatial memory scores in the genetically identical co-twin, suggesting this relation to be driven by factors that are shared within these twin-pairs (genes/environment). However, as the association was no longer present after correction for age, it is possible that the association resulted from the fact that both amyloid aggregation and memory dysfunction increase with age in a parallel way (Jansen, et al., 2017) . Using amyloid PET status of monozygotic amyloid discordant and concordant twins as a disease staging model for amyloid pathology, we found that Rey visuospatial memory scores in concordant amyloid positive twins were worse relative to concordant and discordant amyloid negative twins, which may suggest that Rey visuospatial memory is impaired in a relatively late stage of amyloid aggregation.
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The fact that the relation between Rey visuospatial memory performance and amyloid abnormality on PET imaging was only found for a visual read of the PET scan, but not with the continuous amyloid PET BP ND , may be explained by the low variability in PET BP ND values, as the large majority of the sample showed low BP ND levels.
Visual associative memory
While visual associative memory was not associated with amyloid aggregation in the total group, monozygotic twin amyloid discordance analysis showed a possible effect of disease staging on visual associative memory with a trend for lower face-name associative memory scores in amyloid PET discordant negative twins and lower scores for amyloid PET concordant positive twin-pairs compared to concordant negative twin-pairs. Contrary to Rentz and colleagues, we did not find that amyloid aggregation was associated with face-name associative memory in the total group. This may be explained by differences in amyloid quantification (global binding in our study versus regional binding in the other study). The absence of the association may also be due to selective drop-out as participants who did not complete the face-name associative memory task were older and had lower cognitive scores.
Cognitive complaints and amyloid aggregation
Amyloid measures did not correlate with cognitive complaints. One other study in community dwelling cognitively normal older adults showed that cognitive complaints were associated with higher amyloid load (Perrotin, et al., 2017) which may be due to differences in definition of cognitive complaints and exclusion criteria used. Cognitive complaints may be more strongly associated with amyloid aggregation in a memory clinic setting . We found no relation between CCI and memory performance, in line with previous studies (Alegret, et al., 2015 ,Snitz, et al., 2015 .
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Strengths and limitations
A strength of this study is the large sample size of cognitively normal older monozygotic twins with amyloid biomarker data on PET, and in a substantial subsample in CSF as well.
Possible limitations are the inclusion and exclusion criteria applied in our study, as these reduced the range of memory performance and CCI scores, which may have limited the ability to detect associations. Our population was relatively healthy with a low prevalence of positive amyloid PET scans (14%), which may have also limited power to detect differences in the continuous PET analyses in relation to memory performance. The number of concordant amyloid positive twin-pairs was relatively small, which limited statistical power.
By design we only included monozygotic twin-pairs and we could therefore not discriminate between the contribution of shared genetics and shared environment to the association between memory and amyloid pathology. However, shared environment is most often not involved, in twin correlations for brain aging markers in older adults (Blokland, et al., 2012 ,Lee, et al., 2010 .
Conclusions
Visuospatial and face-name associative memory are among the types of memory sensitive for early AD. Our monozygotic twin study provides a useful approach to clarify mechanisms behind early amyloid pathology and memory loss in AD.
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Amyloid and memory in cognitively normal older adults - Konijnenberg et al. 2018 21 Tables & Figure legends Generalized estimating equations are shown unadjusted (model 1) and covariate unadjusted (age, gender, and education (model 2)). *significant after correction for multiple testing (Bonferroni corrected p<0.05 = 0.05/10 = 0.005). All models included random effect for twin status. Beta is z-scores of standardized residuals. A higher PET BP ND and a lower CSF amyloid β 1-42/1-40 ratio indicate higher amyloid load.
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Amyloid and memory in cognitively normal older adults - Konijnenberg et al. 2018 23 Figure 1 . Twin analyses on relation between amyloid markers and memory Illustration of analyses performed. a) association between amyloid measures and memory in total group; b) cross-twin cross-trait analysis: amyloid measure in one twin is correlated with memory score in the co-twin, a significant cross-twin correlation indicates that the relation is in part driven by common genetic and/or environmental factors; c) within twin-pair difference analysis: within twin-pair difference in amyloid measures is associated with within twin-pair difference in memory score, a significant within twin-pair difference association indicates that the relation is partly driven by unique environmental factors. Boxplots show Rey 3 minute recall scores (A), FNAME-name subscore (B), PAL total errors score (C), RAVLT delayed recall score (D), and CCI self-reported score (E) for twins from pairs that have both a negative amyloid PET scan (concordant negative, N pairs =74), twin from a discordant pair with negative amyloid-PET scan (discordant negative, n=14), twin from a discordant pair with positive amyloid-PET scan (discordant positive, n=14), and twins from pairs that have both a positive PET scan (concordant positive N pairs =6). For tests that showed overall significance we indicated which group comparisons were significant **p<0.01, *p <0.05, or showed a trend # p<0.10 (corrected for age, gender, and education). FNAME: facename associated memory exam; PAL: paired associate learning; RAVLT: Rey auditory verbal learning task; CCI: cognitive change index self-reported.
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